Effect of nontoxic heat shock protein 90 inhibitor peptide derivatives on reversal of MDR of tumor cells

Joseph Molnár, Helga Engi, Yvette Mándi, Csaba Somlai, Botond Penke, Andrea Szabó, Antal Orosz

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Novel heat shock protein 90 inhibitor peptide derivatives [D-Trp-Phe-D-Trp-Leu-AMB (1), p-HOPA-D-Trp-Phe-D-Trp-Leu-ψ(CH2NH)-Leu-NH2 (2), D-Trp-Phe-D-Trp-OH (3), Suc-D-Trp-Phe-D-Trp-Leu-AMB (4), D-Tyr-Phe-D-Trp-Leu-AMB (5), D-Arg-D-Trp-Phe-D-Trp-Leu-Leu-NH2 (6), Leu-ψ(CH2NH)-Leu-NH2×2HCl (7), Phe-Trp-Phe-Trp-Leu-Leu-NH2 (8), Tyr-Trp-Phe-Trp-Leu-Leu-NH2 (9) and Tyr-D-Trp-Phe-D-Trp-Leu-Leu-NH2 (10)] were synthetized, and their ability to reverse multidrug resistance (MDR) was studied. Peptide derivatives 1, 4 and 5, with D-Trp or D-Tyr residues in the N-terminal position caused a marked inhibition of MDR in cancer cells. These MDR inhibitor compounds and epirubicin were demonstrated to have additive and synergistic antiproliferative effects in checkerboard experiments on human MDR1 gene-transfected mouse lymphoma cells in vitro. It is suggested that the MDR reversal effects of these anticancer peptide derivatives, together with their antiproliferative effects on lung cancer cells, may open up new horizons in cancer chemotherapy.

Original languageEnglish
Pages (from-to)429-434
Number of pages6
JournalIn Vivo
Volume21
Issue number2
Publication statusPublished - Mar 1 2007

Keywords

  • Heat shock protein 90 inhibitor
  • MDR reversal

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology

Fingerprint Dive into the research topics of 'Effect of nontoxic heat shock protein 90 inhibitor peptide derivatives on reversal of MDR of tumor cells'. Together they form a unique fingerprint.

  • Cite this